ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Relationship Between International Normalized Ratio to Albumin Ratio and Mortality in Critically Ill Patients With Myocardial Infarction.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundMyocardial infarction (MI) continues to be one of the leading causes of morbidity and death worldwide. The international normalized ratio (INR) to albumin ratio (PTAR), calculated as INR divided by serum albumin, is a composite biomarker reflecting both nutritional status and coagulation abnormalities. While PTAR has shown prognostic relevance across various severe clinical scenarios, its role in forecasting mortality among critically ill MI patients remains insufficiently defined. The objective of this study was to examine the relationship between PTAR and all-cause mortality, and to evaluate its predictive capability through machine learning models.MethodsData from 1616 critically ill MI patients were retrieved from Version 3.1 of the MIMIC-IV database. The primary and secondary outcomes were 30- and 360-day all-cause hospital mortality. The relationship between PTAR and mortality was evaluated using multivariate Cox regression models, and nonlinear associations were further explored through restricted cubic spline (RCS) analysis. Survival analysis was performed using the Kaplan-Meier method. Feature variables were selected through the Boruta algorithm, and eight machine learning models were constructed to evaluate predictive performance.ResultsElevated PTAR levels were independently associated with increased risks of mortality at both 30 and 360 days. In Cox models with full adjustment, participants in the highest PTAR tertile showed a substantially higher risk of mortality relative to those in the lowest category (HR = 2.09, 95% CI: 1.53-2.86 for 30-day mortality; HR = 2.15, 95% CI: 1.69-2.73 for 360-day mortality). RCS analysis demonstrated that the mortality risk increased in a nonlinear fashion with rising PTAR values. Subgroup analyses revealed consistent predictive value across all subgroups. The Boruta algorithm ranked PTAR among the top predictors of mortality. Comprehensively considering the AUC value, calibration curve, and decision curve, the predictive model using LightGBM demonstrated the best performance (AUC = 0.7861).ConclusionOur study revealed a strong positive association between the PTAR and the mortality risk in critically ill patients with MI. Higher PTAR is associated with greater mortality risk. Predictive models based on machine learning demonstrated good performance. These findings suggest that PTAR may serve as a potential predictor of adverse outcomes in critically ill MI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.